-
Capivasertib Extends Progression-Free Survival in Hormone Receptor-Positive Breast Cancer
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
by Eric Fitzsimmons
-
Pregnancy After a Breast Cancer Diagnosis
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
by Thomas Celona
-
Disparities in Breast Cancer Outcomes for Black Women Despite Similar Recurrence Scores
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
by Eric Fitzsimmons
Cancer Talk
An Evidence-Based Guide to Integrative Medicine
ASCO and the Society for Integrative Oncology issue recommendations for integrative medicine approaches that have been supported with research.
by Teresa Bergen
Comparing Costs of At-Home Colorectal Screening TestsCologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.
by Jon Kelvey
A Personal Journey of Thyroid Cancer TreatmentThe practical side of cancer treatment and life without a thyroid.
by Carly Flumer
Women Less Satisfied With Cancer CareCompared with men, women’s initial cancer symptoms are less likely to be taken seriously.
by Sandra Gordon
From the AACR
-
From Dry January to Sober October: Cutting Back on Alcohol
If you toasted 2023 with champagne, then woke up pledging a month of sobriety, you’re not alone.
-
AACR Cancer Progress Report
The vital importance of research for improving health and saving lives from cancer is highlighted in this twelfth edition of the annual American Association for Cancer Research (AACR) Cancer Progress Report.
Video
Drugging the Elusive KRAS
